124 related articles for article (PubMed ID: 2822918)
1. Current management of low-risk metastatic gestational trophoblastic disease.
Jones WB
J Reprod Med; 1987 Sep; 32(9):653-6. PubMed ID: 2822918
[TBL] [Abstract][Full Text] [Related]
2. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study.
Curry SL; Blessing JA; DiSaia PJ; Soper JT; Twiggs LB
Obstet Gynecol; 1989 Mar; 73(3 Pt 1):357-62. PubMed ID: 2536911
[TBL] [Abstract][Full Text] [Related]
4. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
Lurain JR; Brewer JI
Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
[TBL] [Abstract][Full Text] [Related]
5. High-risk metastatic gestational trophoblastic tumors. Current management.
Lurain JR
J Reprod Med; 1994 Mar; 39(3):217-22. PubMed ID: 7518518
[TBL] [Abstract][Full Text] [Related]
6. Management of high-risk gestational trophoblastic disease.
Surwit EA
J Reprod Med; 1987 Sep; 32(9):657-62. PubMed ID: 2822919
[TBL] [Abstract][Full Text] [Related]
7. Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease.
Dobson LS; Lorigan PC; Coleman RE; Hancock BW
Br J Cancer; 2000 May; 82(9):1547-52. PubMed ID: 10789722
[TBL] [Abstract][Full Text] [Related]
8. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
[TBL] [Abstract][Full Text] [Related]
9. [Methotrexate in gynecologic oncology].
Isonishi S; Terashima Y
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1896-900. PubMed ID: 8978793
[TBL] [Abstract][Full Text] [Related]
10. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens.
Abrão RA; de Andrade JM; Tiezzi DG; Marana HR; Candido dos Reis FJ; Clagnan WS
Gynecol Oncol; 2008 Jan; 108(1):149-53. PubMed ID: 17931696
[TBL] [Abstract][Full Text] [Related]
11. Metastatic gestational trophoblastic disease: experience at the New England Trophoblastic Disease Center, 1965 to 1985.
DuBeshter B; Berkowitz RS; Goldstein DP; Cramer DW; Bernstein MR
Obstet Gynecol; 1987 Mar; 69(3 Pt 1):390-5. PubMed ID: 3029641
[TBL] [Abstract][Full Text] [Related]
12. The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D.
Soto-Wright V; Goldstein DP; Bernstein MR; Berkowitz RS
Gynecol Oncol; 1997 Jan; 64(1):156-9. PubMed ID: 8995566
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report.
Taran A; Ignatov A; Smith B; Bischoff J; Costa SD
Am J Obstet Gynecol; 2008 Nov; 199(5):e6-8. PubMed ID: 18984073
[TBL] [Abstract][Full Text] [Related]
14. Metastatic gestational trophoblastic disease: prognostic factors in previously untreated patients.
Soper JT; Clarke-Pearson D; Hammond CB
Obstet Gynecol; 1988 Mar; 71(3 Pt 1):338-43. PubMed ID: 2831487
[TBL] [Abstract][Full Text] [Related]
15. Gestational trophoblastic disease.
Hammond CB; Olt GJ
Curr Ther Endocrinol Metab; 1994; 5():567-70. PubMed ID: 7704794
[No Abstract] [Full Text] [Related]
16. Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role?
Gillespie AM; Siddiqui N; Coleman RE; Hancock BW
Br J Cancer; 1999 Mar; 79(7-8):1270-2. PubMed ID: 10098770
[TBL] [Abstract][Full Text] [Related]
17. Gestational trophoblastic disease presenting as a large metastasis to the finger.
Hetzel DJ; Olt GJ; Sorosky JI; Mortel R; Singapuri K; Podczaski ES
Gynecol Oncol; 1996 Oct; 63(1):123-6. PubMed ID: 8898181
[TBL] [Abstract][Full Text] [Related]
18. Placental site trophoblastic tumor: an overview.
Bonazzi C; Urso M; Dell'Anna T; Sacco S; Buda A; Cantú MG
J Reprod Med; 2004 Aug; 49(8):585-8. PubMed ID: 15457847
[TBL] [Abstract][Full Text] [Related]
19. [Magnetic resonance tomography in follow-up of hydatidiform mole].
Marth C; Judmaier W; Helweg G; Schwegel P; Wicke K; Zeimet AG; Daxenbichler G; Hetzel H
Geburtshilfe Frauenheilkd; 1992 Aug; 52(8):501-3. PubMed ID: 1327942
[TBL] [Abstract][Full Text] [Related]
20. Management of low-risk metastatic gestational trophoblastic tumors.
DuBeshter B; Berkowitz RS; Goldstein DP; Bernstein MR
J Reprod Med; 1991 Jan; 36(1):36-9. PubMed ID: 1848898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
